Dr. Brian Kotzin Resigns from Rigel Pharmaceuticals’ Board
Company Announcements

Dr. Brian Kotzin Resigns from Rigel Pharmaceuticals’ Board

An announcement from Rigel ( (RIGL) ) is now available.

Dr. Brian Kotzin has decided to step down from his role as an independent director on Rigel Pharmaceuticals’ Board of Directors, as well as from all board committees he serves on, effective September 16, 2024. His resignation is amicable and not due to any disputes concerning Rigel’s operational, policy, or practice matters.

Find detailed analytics on RIGL stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyRigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial
TheFlyRigel Pharmaceuticals enters license and supply agreement with Kissei Pharma
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App